Kenneth S Koblan - Net Worth and Insider Trading
Kenneth S Koblan Net Worth
The estimated net worth of Kenneth S Koblan is at least $96,015 dollars as of 2024-11-13. Kenneth S Koblan is the Chief Scientific Officer of Alnylam Pharmaceuticals Inc and owns about 357 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $96,015. Details can be seen in Kenneth S Koblan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth S Koblan has not made any transactions after 2010-12-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kenneth S Koblan
Kenneth S Koblan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth S Koblan owns 1 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) .
Click here to see the complete history of Kenneth S Koblan’s form 4 insider trades.
Insider Ownership Summary of Kenneth S Koblan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2010-12-08 | Chief Scientific Officer |
Kenneth S Koblan Latest Holdings Summary
Kenneth S Koblan currently owns a total of 1 stock. Kenneth S Koblan owns 357 shares of Alnylam Pharmaceuticals Inc (ALNY) as of December 8, 2010, with a value of $96,015.
Latest Holdings of Kenneth S Koblan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2010-12-08 | 357 | 268.95 | 96,015 |
Holding Weightings of Kenneth S Koblan
Kenneth S Koblan Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth S Koblan has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 0 shares on December 8, 2010, which brought Kenneth S Koblan around $0.
Insider Trading History of Kenneth S Koblan
- 1
Kenneth S Koblan Trading Performance
Kenneth S Koblan Ownership Network
Ownership Network List of Kenneth S Koblan
Ownership Network Relation of Kenneth S Koblan
Kenneth S Koblan Owned Company Details
What does Alnylam Pharmaceuticals Inc do?
Who are the key executives at Alnylam Pharmaceuticals Inc?
Kenneth S Koblan is the Chief Scientific Officer of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Yvonne Greenstreet , EVP & Chief Commercial Officer Tolga Tanguler , and CMO & EVP Dev & Med Affairs Pushkal Garg .
Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary
Over the past 18 months, Kenneth S Koblan made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 52,531 shares made by Yvonne Greenstreet , a net sale of 10,304 shares made by Pushkal Garg , and a net sale of 5,639 shares made by Jeffrey V. Poulton .
In summary, during the past 3 months, insiders sold 15,000 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 15,000 shares. During the past 18 months, 249,128 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 249,128 shares.
Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alnylam Pharmaceuticals Inc Insider Transactions
Kenneth S Koblan Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth S Koblan. You might contact Kenneth S Koblan via mailing address: 300 Third Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
